Literature DB >> 25788189

Can hypersplenism secondary to portal hypertension be treated by non-selective beta blockers?

Moon Young Kim1, Yasuko Iwakiri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25788189      PMCID： PMC5046185          DOI： 10.1007/s12072-014-9601-1

Source DB:  PubMed          Journal:  Hepatol Int        ISSN： 1936-0533            Impact factor:   6.047


× No keyword cloud information.
  10 in total

Review 1.  Management of varices and variceal hemorrhage in cirrhosis.

Authors:  Guadalupe Garcia-Tsao; Jaime Bosch
Journal:  N Engl J Med       Date:  2010-03-04       Impact factor: 91.245

Review 2.  Medical management of esophageal varices and portal hypertension in children.

Authors:  Lorenzo D'Antiga
Journal:  Semin Pediatr Surg       Date:  2012-08       Impact factor: 2.754

3.  β-Blocker therapy ameliorates hypersplenism due to portal hypertension in children.

Authors:  Ujjal Poddar; Upender Shava; Surender Kumar Yachha; Jaya Agarwal; Sheo Kumar; Sanjay S Baijal; Anshu Srivastava
Journal:  Hepatol Int       Date:  2014-09-23       Impact factor: 6.047

4.  A cohort study of childhood hypertrophic cardiomyopathy: improved survival following high-dose beta-adrenoceptor antagonist treatment.

Authors:  I Ostman-Smith; G Wettrell; T Riesenfeld
Journal:  J Am Coll Cardiol       Date:  1999-11-15       Impact factor: 24.094

5.  Prevalence of peripheral blood cytopenias (hypersplenism) in patients with nonalcoholic chronic liver disease.

Authors:  F N Bashour; J C Teran; K D Mullen
Journal:  Am J Gastroenterol       Date:  2000-10       Impact factor: 10.864

6.  Relevance of the mTOR signaling pathway in the pathophysiology of splenomegaly in rats with chronic portal hypertension.

Authors:  Marc Mejias; Ester Garcia-Pras; Javier Gallego; Raul Mendez; Jaime Bosch; Mercedes Fernandez
Journal:  J Hepatol       Date:  2010-02-04       Impact factor: 25.083

7.  Primary prophylaxis of gastroesophageal variceal bleeding: consensus recommendations of the Asian Pacific Association for the Study of the Liver.

Authors:  Shiv Kumar Sarin; Ashish Kumar; Peter W Angus; Sanjay Saran Baijal; Yogesh Kumar Chawla; Radha Krishna Dhiman; H Janaka de Silva; Saeed Hamid; Shozo Hirota; Ming-Chih Hou; Wasim Jafri; Mobin Khan; Laurentius A Lesmana; Hock F Lui; Veena Malhotra; Hitoshi Maruyama; Debendranath Guha Mazumder; Masao Omata; Ujjal Poddar; Amrinder S Puri; Praveen Sharma; Huma Qureshi; Rizvi Moattar Raza; Peush Sahni; Puja Sakhuja; Mohammad Salih; Amal Santra; Barjesh Chander Sharma; Hasnain Ali Shah; Gamal Shiha; Jose Sollano
Journal:  Hepatol Int       Date:  2008-09-05       Impact factor: 6.047

8.  Propranolol ameliorates thrombocytopenia in patients with cirrhosis.

Authors:  Kenji Sakai; Tadashi Iwao; Kazuhiko Oho; Atsushi Toyonaga; Michio Sata
Journal:  J Gastroenterol       Date:  2002       Impact factor: 7.527

Review 9.  Thrombocytopenia associated with chronic liver disease.

Authors:  Nezam Afdhal; John McHutchison; Robert Brown; Ira Jacobson; Michael Manns; Fred Poordad; Babette Weksler; Rafael Esteban
Journal:  J Hepatol       Date:  2008-03-31       Impact factor: 25.083

10.  Improvement of thrombocytopenia due to hypersplenism after transjugular intrahepatic portosystemic shunt placement in cirrhotic patients.

Authors:  O A Alvarez; G A Lopera; V Patel; C E Encarnacion; J C Palmaz; M Lee
Journal:  Am J Gastroenterol       Date:  1996-01       Impact factor: 10.864
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.